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Abstract 
Covalent chemical modifications, including the acetylation of core histone proteins and 
methylation of cytosine in or near promoter regions of DNA, influence the efficiency with which 
genes are transcribed.  Chemical modifications that regulate gene expression within postmitotic 
differentiated neurons can reflect environmental influences, including exposure to stress.  These 
chemical modifications or “marks” may reflect downstream consequences of the transduction of 
extracellular chemical messengers, such as neurotransmitters, growth factors and hormones, by 
receptors located at the surface of the neuron or within the cell itself.  The ability to decipher 
the epigenetic code may serve as a record of early childhood adversity that sensitizes to 
additional epigenetic changes caused by traumatic exposures in adulthood.  Further, epigenetic 
therapeutic interventions may be possible that would attenuate the severity of adverse 
consequences associated with traumatic exposures in the child and adult.  Ideally, targeted 
epigenetic therapeutic interventions would address stress-induced dysregulation of the 





Ultimately, receptor-mediated, activity-dependent signaling pathways that are initiated at the 
cell surface influence gene expression within the nucleus.  Within post-mitotic, terminally 
differentiated neurons, enduring experience-dependent changes in gene expression underlie 
changes in synaptic strength within specific circuits, contributing to the plasticity that is 
necessary for learning and memory, stress responsivity, and substance abuse and psychiatric 
disorders (Deutsch et al., 2008b; Malan-Muller et al., 2013; Maze et al., 2013; Sun et al., 2013; 
Sweatt, 2013; Zhang et al., 2013; Zovkic & Sweatt, 2013).  Chromatin remodeling affecting the 




promoter regions of genes, which influences the efficiency of transcription, has emerged as an 
important mechanism of experience-dependent neuroplasticity.  Importantly, the epigenetically 
determined enduring changes in gene expression do not result from changes or mutations in the 
sequence of nucleic acids in DNA, rather they often result from covalent modifications of 
histone proteins (e.g., changes in the acetylation and methylation states of lysine residues) and 
cytosine residues within the DNA molecule (e.g., methylation or hydroxymethylation), leading to 
activating or repressive effects on gene expression.  With respect to the brain, the definition of 
epigenetics has broadened to include “chromatin-regulating molecular mechanisms in 
nondividing neuronal cells” (Zovkic & Sweatt, 2013).  Chromatin is the structure that enables 
approximately 2 meters of double-stranded DNA to be compacted into a nucleus, whose 
microscopic diameter can be approximately 5 µM.  The nucleosome is the repeating unit of 
chromatin and consists of approximately 147 base pairs of superhelical DNA wrapped around an 
octamer of four highly conserved core histone proteins: designated H2A, H2B, H3 and H4.  The 
nucleosomes are linked to a fifth histone protein (i.e., H1), which is important for chromatin 
compaction and its higher-order structure (Deutsch et al., 2008b; Malan-Muller et al., 2013; 
Maze et al., 2013; Sun et al., 2013; Sweatt, 2013; Zhang et al., 2013; Zovkic & Sweatt, 2013).   
 
Chromatin Remodeling Enzymes 
Transcriptional efficiency can also be affected by ATP-dependent chromatin remodeling 
enzymes that affect the higher-order structure of chromatin (Maze et al., 2013).  These enzymes 
are oligomeric proteins with distinct functional domains, including domains that “read” or 
recognize distinct “markers” or covalent modifications of histone proteins and a domain with 
ATPase activity that uses ATP, the biological energy currency, to change the structure of 
chromatin.  ATP-dependent chromatin remodeling complexes can participate in transcriptional 
activation or repression at a given locus, which is determined by their association with effector 
proteins, including transcription factors.      
 
Histone Modifications 
A major mechanism of chromatin remodeling involves covalent modifications of core histone 
proteins, which occur primarily on highly conserved basic amino acid sequences (especially 
lysine residues) located at the amino and carboxy terminal tails (Deutsch et al., 2008b; Maze et 




methylation, phosphorylation, and ubiquitination, among other types of covalently attached 
groups.  In general, the acetylation of lysine residues in the N-terminal tail region by histone 
acetyltransferases (HATs), which comprise a large class of “writers,” results in gene activation; 
the specific acetyl-lysine modifications are referred to as bromodomains and recognized by 
specific “readers.”  Histone acetylation results in a reduction or neutralization of the positive 
charge of core histone proteins that relaxes the electrostatic affinity between the positively-
charged histones and negatively charged DNA.  Acetylation is the most studied posttranslational 
covalent modification of histone proteins.   
 
Because of the strength of carbon-carbon bonds, the turnover kinetics of histone methylation is 
slow and these “marks” can assume multiple valence states (i.e., mono, di, and trimethylated 
forms) that can serve as the basis of lifelong “epigenetic memory;” methylation occurs at lysine 
and arginine residues.  However, contrary to the former belief that histone methylation “marks” 
were stable and lasted indefinitely, it is now known that these marks, including the valence 
states, can also reflect dynamic interactions between multiple distinct histone 
methyltransferases (HMTs) and histone demethylases (HDMs).  In contrast to acetylation, which 
is usually associated with promotion of gene expression, histone methylation can be associated 
with gene activation or repression, which is determined by the specific basic amino acid residues 
that are methylated, interactions with other histone “marks,” and the valence state of the 
methylated amino acid.  Thus, methylation of lysine residues 4 or 36 on H3 are most often 
associated with the promotion of gene expression, whereas methylation of lysine residues 9 or 
27 are commonly associated with gene silencing.  Rapid and transient phosphorylation of serine 
residues in the core H3 histone protein (e.g., the serine 10 residue) has also been shown to 
result from stimulation of cultured striatal neurons and the hippocampal dentate gyrus by 
growth factors and neurotransmitters.  Interestingly, the affinity of the chaperone “reader” 
protein 14-3-3 for the phosphorylated H3 histone in the serine 10 position is increased by the 
presence of an acetyl group on the neighboring lysine in the 14 position, which leads to 
transcriptional activation.  The data support the importance of “readers” that recognize distinct 
combinations of histone marks (Maze et al., 2013).            
 
The relaxation of compacted chromatin can promote gene expression by enabling the 




2013).  As mentioned, the histone modifications or “markers” are “read” by specific proteins, 
which can lead to activation or repression of transcription and gene expression.  Importantly, 
the readers often have multiple binding domains that recognize and bind to different histone 
marks simultaneously; thus, deciphering the “histone epigenetic code” and understanding the 
functional output of modified chromatin requires examination of multivalent modifications both 
within (i.e., intra) and between (i.e., inter) nucleosomes.  The histone modifications act in a 
combinatorial manner to influence gene expression.  In addition to their association with 
transcription complexes, “readers” may have domains or be associated with enzymes that can 
affect other histone modifications or ATP-dependent chromatin remodeling.  As reviewed, 
chromatin output in post-mitotic, terminally differentiated neurons is a dynamic process that 
reflects experience-induced changes in histone modifications or “marks.”  The ability of 
“readers” to integrate and transduce these “marks” into chromatin output reflects, in part, a 
dynamic relationship between “writers” (e.g., HATs and HMTs), and “erasers” (e.g., histone 
deacetylases [HDACs] and HDMs); erasers enzymatically remove specific histone modifications.  
Ultimately, chromatin output reflects reading of the “histone epigenetic code,” whose 
coordinated components include histone modifications, DNA methylation, noncoding RNAs, and 
transcription factors.       
 
DNA Methylation 
Within intergenic regions, DNA methylation is responsible for the silencing and suppression of 
expression of transposable and viral elements, which, if expressed, would be harmful (Moore et 
al., 2013).  DNA methylation is also important for the establishment of imprinting, which is a 
process whereby genes are preferentially expressed from only one of the two parental 
chromosomes (Moore et al., 2013).  Additionally, DNA methylation is a mechanism regulating 
the differentiation of cells from pluripotent stem cells during development.  Finally, DNA 
methylation represents a mechanism for transducing experiences into long-lasting changes in 
gene expression, and serves as a major mechanism of epigenetic regulation.  Most commonly, 
DNA methylation in the promoter region of genes enriched in cytosine-guanine (CpG) 
dinucleotides (so-called CpG islands) leads to transcriptional silencing.  About 70% of gene 
promoters reside within CpG islands and these CpG islands are conserved between mice and 
humans, consistent with their functional importance.  Specifically, DNA methylation involves the 




donor, to the carbon-5 position on cytosine.  Importantly, the epigenetic marks of 5-
methylcytosine and 5-hydroxymethylcytosine cannot be differentiated by the current 
conventional high-throughput methods for mapping patterns of DNA methylation (i.e., bisulfite 
sequencing and the use of methylation-sensitive restriction enzymes).  5-Hydroxymethylcytosine 
influences gene expression, similar to 5-methylcytosine, and is also an intermediate in a 
pathway that leads to DNA demethylation.         
 
The DNA methyltransferases (DNMTs) that are involved in maintenance and perpetuation of 
patterns of DNA methylation constitute one of the two broad families of DNMTs (Moore et al., 
2013).  This group of enzymes includes DNMT1, which recognizes the methylated CpG 
dinucleotide on the hemi-methylated strand and converts unmethylated CpG on its 
complementary strand into a methylated CpG.  The other broad family of DNMTs is the de novo 
DNMTs, including DNMT3a and DNMT3b, which methylate previously unmethylated cytosines in 
CpG dinucleotides.  In general, the de novo DNMTs create a new methylation pattern of 
unmodified or naked DNA, whereas DNMT1 functions during DNA replication to assure that the 
pattern of DNA methylation is preserved in daughter strands.  With respect to de novo DNA 
methylation, transcription factors are thought to play a regulatory role in determining which 
regions of DNA are to be methylated.  Before or after binding to specific DNA sequences, 
transcription factors may act by recruiting DNMTs or, alternatively, their binding may protect 
CpG sites from de novo methylation.  In addition to its activity during DNA replication, DNMT1 
also “repairs” DNA methylation preserving and maintaining a differentiated cell’s pattern of DNA 
methylation.  Recent research on disorders such as schizophrenia and hereditary sensory and 
autonomic neuropathy type 1 (HSAN1) support an important epigenetic role of DNMT1 in post-
mitotic neurons in the adult brain.  In fact, because no dramatic changes in DNA methylation 
patterns in forebrain postmitotic neurons are observed in transgenic knockout mice with absent 
expression of DNMT1 or DNMT3a, it is thought that these two DNMTs may have overlapping 
roles in these postmitotic neurons (Moore et al., 2013).   
 
DNA demethylation is an active metabolic process whereby a series of sequential chemical 
reactions leads to deamination and oxidation of 5-methyl-cytosine to a product that is a 
substrate for the “base excision repair (BER)” pathway; there is no known enzymatic mechanism 




the 5-position (Moore et al., 2013).  The ultimate product of the processing of 5-methyl-cytosine 
results in a base-pair mismatch that is subject to BER.  As noted, 5-hydroxymethyl-cytosine is an 
intermediate in one of the DNA demethylation pathways that may also have a role in the 
epigenetic regulation of gene expression.  For example, 5-hydroxymethyl-cytosine interferes 
with the binding of MeCP2 to methylated DNA; MeCP2 is a methyl-CpG-binding protein that 
contributes to gene repression.  The family of methyl-CpG binding proteins are more highly 
expressed in brain than other tissues, and may possess a “transcriptional repression domain” 
that binds to repressor complexes (Moore et al., 2013).  In addition to active gene repression, 
MeCP2 has a probable role in the maintenance of DNA methylation patterns because it binds to 
DNMT1.  MeCP2 is also a substrate for posttranslational phosphorylation induced by neuronal 
activity, which would release it from promoter regions, making these sequences accessible to 
active DNA demethylation and, thereby, promoting gene expression.  That MeCP2 is a critical 
methyl-CpG-binding protein is supported by the fact that its mutation results in Rett Syndrome, 
a neurodevelopmental disorder.     
 
Epigenetic Changes Mediate Contextual Fear Conditioning 
Contextual fear conditioning in rodents is a form of hippocampal-dependent associative learning 
in which an aversive unconditioned stimulus, such as foot shock, becomes associated with the 
context or place (i.e., conditioned stimulus) in which the aversive stimulus was delivered (Zovkic 
& Sweatt, 2013).  Once the long-term association memories in the fear conditioning paradigm 
become consolidated, freezing behavior, the unconditioned response to the aversive foot shock, 
is observed or elicited whenever the animals are placed in the context where the foot shock was 
originally delivered. (i.e., conditioned response).  A variety of epigenetic changes have been 
described in the hippocampus as a result of this fear conditioning procedure.  Some of the 
observed changes in hippocampus are time-dependent, including reversion to baseline levels 
within 24 hours, reflecting, perhaps, the processes of memory consolidation in hippocampus 
and downloading of these memories in the cortex for long-term storage and maintenance.  The 
changes in hippocampus associated with contextual fear conditioning included acetylation of H3 
histone protein in the CA1 region; moreover, treatment of adult animals with histone 
deacetylase (HDAC) inhibitors and, thereby, increasing the acetylation status of H3 led to 
enhanced memory formation.  Complementary changes were also observed in DNA methylation 




upregulation in the hippocampal expression of DNMT 3a and 3b, which led to methylation and 
transcriptional silencing of a memory suppressor gene (i.e., protein phosphatase 1).  There was 
also DNA demethylation and transcriptional activation of the genes coding for reelin and brain-
derived neurotrophic factor (BDNF), which are two proteins important for experience-induced 
neuroplasticity.  Interestingly, contextual fear conditioning was associated with increased H3 
histone acetylation at BDNF promoter regions, supporting the coordinated activity of DNA 
methylation and histone acetylation in the regulation of BDNF expression.  The changes in levels 
of DNA methylation for protein phosphatase 1 and reelin in hippocampus returned to baseline 
within 24 hours (Zovkic & Sweatt, 2013).  An inability to extinguish learned fear responses is a 
major etiological theory of PTSD.  The persistence of learned fear responses may ultimately 
reflect enduring epigenetic changes due to covalent modifications of histone tails and DNA.     
 
Environmental-Induced Epigenetic Modifications Mediate Hypothalamic-Pituitary-Adrenal 
Axis Dysregulation in Response to Childhood Adversity and Adult Trauma Exposures 
A major role of the hypothalamic-pituitary-adrenal (HPA) axis is the maintenance of “allostasis,” 
which is the maintenance of stability in spite of stressful or unanticipated environment 
exigencies (McGowan, 2013).  Childhood adversity can impact the ability of the HPA axis to 
maintain allostasis and is a major risk factor for posttraumatic stress disorder (PTSD).  Current 
research on the epigenetic consequences of early life adversity focuses on identifying labile 
areas of the genome that are sensitive to modifications by environmental factors and the 
ontological time course of epigenetic changes (i.e., when during development are epigenetic 
changes most likely to occur in response to specific types of adversity).  Animal models of early 
life adversity have clearly shown that the quality of maternal care influences offspring response 
to novel and stressful environments, which are mediated, at least in part, by epigenetic changes 
in the HPA circuitry of the offspring.  Thus, the quality of maternal care in rats influences lifelong 
changes in the DNA methylation pattern in hippocampus of the untranslated 17 splice variant of 
the glucocorticoid receptor (GR) promoter, as well as the acetylation status of the lysine 9 
residue of the H3 histone protein in offspring (Daskalakis et al., 2013; Malan-Muller et al., 2013; 
McGowan, 2013; Sweatt, 2013; Yehuda & LeDoux, 2007; Yehuda & Bierer, 2009; Yehuda et al., 
2013).  The quality of maternal care has also been shown to affect the epigenetic regulation of a 
variety of regions in the offspring’s brains, including the GAD67 gene involved in synthesis of 




vasopressin in hypothalamus, and the gene for BDNF in prefrontal cortex and hippocampus, 
among other genes and regions.  Translational studies in postmortem human brain have shown 
that a history of child abuse affects the extent of DNA methylation of the exon 1F promoter 
region of the gene for the GR in the hippocampus of suicide victims; thus, suicide victims and 
controls without histories of abuse or severe neglect in childhood had lower levels of DNA 
methylation of this promoter region, than suicide victims with childhood histories of abuse and 
neglect.             
 
HPA axis dysregulation, increased glucocorticoid sensitivity, and hypocortisolemia can occur in 
patients with PTSD, which could reflect epigenetic modifications of the cytosine methylation 
status in promoter regions of the genes for both the GR and the FK506 binding protein (FKBP5), 
the latter protein regulates the efficiency of intracellular signaling mediated by the GR (Yehuda 
et al., 2013).  There are also emerging data that the expression of these and, perhaps, other 
glucocorticoid related genes can be environmentally regulated throughout life.  In fact, 
preliminary data suggest that Prolonged Exposure (PE) therapy, an evidence-based cognitive-
behavioral intervention for PTSD, can regulate the epigenetic state of FKBP5, which is associated 
with a positive therapeutic response to treatment (Yehuda et al., 2013).  As discussed, in a rat 
model, differences in maternal grooming of pups regulated the cytosine methylation status in 
hippocampus of the exon 17 promoter of the GR gene.  Translational studies in the human 
confirmed that childhood adversity is associated with increased methylation of the human 
ortholog of the rat exon 17 promoter of the GR gene (i.e., the exon 1F promoter), resulting in 
lower expression of GR in hippocampus and a dysregulated HPA axis response to stress.  These 
data are consistent with a literature on premorbid risk factors for PTSD.  Altered levels of 
expression of FKBP5 appear to act as an intracellular feedback loop regulating the signaling 
consequences of GR activation; FKBP5 is a co-chaperone of the GR that decreases the binding of 
ligands to the cytosolic GR and impairs translocation of the ligand-bound GR to the nucleus from 
the cytoplasm.  Thus, increased expression of FKBP5 would dampen activation of the GR.  
Ultimately, the methylation state of FKBP51, the gene coding FKBP5, reflects an interaction 
between genetic variations in the sequence of its nucleotides (i.e., polymorphisms) and 
childhood adversity, and the interaction of genetic variants of FKBP51 and childhood adversity 
contribute to risk for major depression, suicide attempts and PTSD (Yehuda et al., 2013).  




for PTSD after exposures to trauma as an adult.  A compelling hypothesis is that epigenetic 
modifications of glucocorticoid related genes are likely to be responsible for both risk and 
perpetuation of PTSD, which is associated with low glucocorticoid levels and increased GR 
sensitivity. 
 
In a small preliminary study, the effects of PE therapy on the methylation state of the promoters 
of the genes for GR and FKBP5 in peripheral blood mononuclear cells was studied in 16 combat 
veterans, eight of whom responded and no longer met diagnostic criteria for PTSD after 12 
weeks of treatment (Yehuda et al., 2013).  Importantly, the methylation status of the exon 1F 
promoter of the human gene for the GR, the homolog of the exon 17 promoter region of the rat 
gene, is influenced by a childhood history of trauma.  Responders to PE therapy showed a 
greater number of methylated CpG sites in the GR exon 1F promoter at baseline prior to 
treatment; however, the extent of methylation did not change after treatment or three-month 
follow-up (Yehuda et al., 2013).  Thus, increased methylation of the exon 1F promoter may be a 
predictor of a good response to PE therapy.  With respect to the promoter region of the FKBP5 
gene, the data suggest that the number of methylated sites decreases in treatment-responders.  
Thus, in patients with PTSD, who have increased sensitivity to glucocorticoids, decreased DNA 
methylation and up-regulated expression of FKBP5 may be a desired therapeutic goal.  The 
upregulated expression of FKBP5 would lead to diminished glucocorticoid activation as a result 
of diminished GR sensitivity.   
 
In summary, the data suggest that enduring positive effects of “psychotherapeutic” 
interventions may be mediated by epigenetic modifications of genes implicated in stress 
responsivity, such as changes in the methylation status of the promoter region of the gene for 
FKBP5.  Conceivably, beneficial effects of nonpharmacological, psychotherapeutic interventions 
for PTSD and other psychiatric disorders may also be associated with changes in expression of 
genes implicated in neuroplasticity, such as the genes coding for reelin and BDNF.  The pattern 
of DNA methylation of the promoter region of the GR gene may inform a history of altered 
stress sensitivity to traumatic exposures, especially exposures in childhood, and also be 
predictive of a positive response to certain therapeutic interventions.  Recent work also 
supports the potential benefits of strategically timed pharmacological interventions to alter 




treating mice with sodium butyrate, a HDAC inhibitor, around the time of their exposure to a 
profound stressor (i.e., forced swimming in cold water) attenuated the severity of the stressed-
induced reduction of dizocilpine’s antiseizure efficacy tested 24 hours after the stressful 
exposure; dizocilpine is a noncompetitive NMDA receptor antagonist.  The dose of sodium 
butyrate was known to increase the acetylation status of histones in the hippocampus.  These 
data support exploration of epigenetic interventions to address stress-induced alterations of 
glutamatergic neurotransmission (Deutsch et al., 2008a).         
 
Conclusions 
The data are converging to show that environmental influences, especially stressful ones, can 
affect expression of genes in specific brain regions; epigenetic modifications, which are covalent 
modifications of histone tails and DNA itself near transcription start sites, can result in enduring, 
even lifelong, modifications of genes mediating the stress response and neuroplasticity.  The 
characterization of these epigenetic modifications will surely contribute to our understanding of 
the environmental contributions to the etiology of psychiatric disorders, especially PTSD, as well 
as present new avenues of possible therapeutic interventions.  Epigenetic therapeutic 
interventions are already being explored in cancer, and there may be some translational 
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